Navigation Links
Nursing Home Workers From Across the Nation to Rally in for Improved Nursing Home Care
Date:10/15/2007

Workers and their supporters to travel by caravan from Toledo, Ohio to

Washington, DC to highlight concerns over private equity takeover of

nation's largest nursing home chain; Wash., DC rally set for Oct 22

WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- Nursing home workers and their supporters from across the nation are traveling to Toledo, Ohio Wednesday Oct. 17 to rally for improved care at the nation's largest nursing home chain as the shareholders of HCR Manor Care vote to approve a $6.3 billion buyout of the company by global buyout giant, The Carlyle Group. There is growing concern that the buyout may come at a high cost to seniors, taxpayers, and workers. The deal is expected to close by the end of year.

Coalitions of nursing home workers, patient advocates, and elected and community leaders in eight states where Manor Care operates have mounted grassroots efforts to protect seniors, taxpayers, and workers who are being put at risk in the deal. The states are Ohio, Pennsylvania, Michigan, Illinois, Florida, Maryland, Wisconsin, and Washington State. In each state, the coalitions are calling on Carlyle to make specific commitments to improve care at Manor Care nursing homes and reaching out to lawmakers and regulators with their concerns about the impact of the deal on seniors, taxpayers, and workers. The multi-state campaign is the largest ever focused on the impact of a private equity buyout on people's lives.

Following the shareholders vote, a group of Manor Care workers and their supporters will travel by caravan through Ohio, Pennsylvania, and Maryland to the Carlyle Group's headquarters in Washington, DC where they plan to hold demonstrations and lobby members of Congress. The caravan will include stops at Manor Care nursing homes, the offices of elected officials and other locations to be announced. The caravan is being organized by the nation's largest healthcare workers union, SEIU (Service Employees Internationa
'/>"/>

SOURCE Service Employees International Union
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. New Technique Enables Better Nursing Of Robin Sequence Infants
3. Nursing A Threat : NHS Nurses May Stage A Royal Protest
4. Joining The Military My Best Move - US Army Nursing Chief
5. Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds
6. Depressed Seniors Resort to Nursing Homes
7. Private Hospitals, Clinics, Nursing Homes Observe Strike
8. New Program Reduces Nursing Home Residents Out Of Emergency Care
9. NHS Protects Job Opportunities for Homegrown Nursing Graduates
10. Nursing a glue-eyed boy
11. Private Nursing Home in Madhya Pradesh Fined For Negligence

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ALLEY, Pa., Dec. 1 Air P... the previously announced sale of the assets of it...er the Airthane® and Versathane® tradena...global polyurethane chemicals producer COIM SpA. ...acturing facility in Paulsboro, N.J. Terms of the ...
(Date:12/1/2009)...TON, Dec. 1 Individuals...likely than those with traditional coverage to exh...ore engaged in wellness programs, and to be more i...in holding down costs, according to survey results...t Research Institute (EBRI). ,, At the same ti...
(Date:12/1/2009)...IX, Dec. 1 Abrazo Media Relations-...sis ( http:// www.pedsorthopaedics.com ) located i...dic surgeon Dr. J. Hunt Udall to its practice. ,...thopaedic surgery after recently completing his fe... Massachusetts where he focused on adult and pedia...
(Date:12/1/2009)...AUDERDALE, Fla., Dec. 1 OrbusNeich...ent in the randomized clinical trial of the Combo ...t). ,, A prospective, randomized, multicenter s... ablu M inal sirolimus coat ED bio- E ngine...20 sites in Asia, Australia, Europe and South Amer...
(Date:12/1/2009)... The ADEAGies Foundation will honor The Forsyth I...the Gies Awards celebration to be held on February...the 2010 ADEA Annual Session & Exhibition. The Wil...hievement recognize contributions to, and support ...or a complete listing of Gies Award winners, visit...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2
...inal Imaging System Allows Primary Care Physicians...l Images, WAKE FOREST, N.C., Sept. 19 Digital He...se management company based in Wake,Forest, NC, an...(R) technology platform. Retasure is a simple, af...
...IEW, Calif., Sept. 20 Cardiva Medical, Inc.,a pri...y that Augustine,Lien, Chairman and CEO, will pres... on Tuesday, September 25th in New York City. Nota...arket,clearance. This new product builds on the su...
...s Position as the Global Leader in Endoscopic Anti...Surgical, Inc. (NDO),announced that the US Food an...Plicator II(TM) multiple implant technology for im...This clearance and the subsequent launch of next-g...
...., Sept. 21 Cephalon, Inc. (Nasdaq:,CEPH) today a...ion (NDA) to,the U.S. Food and Drug Administration...tine HCl) for the treatment of patients with chron...e United States, according to the National Cancer ...
...) receives FDA clearance, REDMOND, Wash., Sept. 2...X(TM) device for performing Transoral Incisionless...troesophageal reflux,disease has received FDA clea...yesterday under general anesthesia,transoral, inci...
...IV Prof. Ehud Assia, of Tel Aviv Universitys Sack...ar in the field of eye surgery. , One of a small ...orm a complicated form of glaucoma surgery, Prof. ... give most practicing eye surgeons the ability to ...
Other Medicine News:Health News:Digital Healthcare Wins FDA Approval for Retasure 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:NDO Receives FDA 510(K) Clearance for Plicator II(TM) 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 3Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 4Health News:Glaucoma surgery in the blink of an eye 2
(Date:12/1/2009)...rts 90 percent radiation reduction in cardiac CT s... -- Dr. James Earls, a radiologist from Fairfax Ra.... will present the findings of a study that shows ...heart patients received from CT scans compared to ...ill present the study to the annual meeting of the...
(Date:12/1/2009)...ERRY HILL, N.J., Dec. 1 ...urprised and delighted when his radiotherapy treat...20 minutes each day to less than five. Midway thr...ware Valley Urology Cancer Center acquired the r...ogy from Varian Medical Systems (NYSE: VAR ), m...
(Date:12/1/2009)...E, Tenn., Dec. 1 Cumberl...d today that an independently conducted study of A...ous N-acetylcysteine, as a cost-saving treatment f... 12, Number 4 of the peer-reviewed Journal of Med...udy concludes that Acetadote is a less costly trea...
Breaking Medicine Technology:Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6Nanoparticles used in common household items caused genetic damage in mice 10748 1Nanoparticles used in common household items caused genetic damage in mice 10748 2Nanoparticles used in common household items caused genetic damage in mice 10748 3Teen Girls at Higher Risk for STDs 3A Report 61460 1Teen Girls at Higher Risk for STDs 3A Report 61460 2Immunity to Swine Flu May Be Broader Than Thought 61457 1Immunity to Swine Flu May Be Broader Than Thought 61457 2Immunity to Swine Flu May Be Broader Than Thought 61457 3
...Congress of European Hematology,Association (EHA) ...tCall/ --,Immunomedics, Inc. , a biopharmaceutical...es to treat cancer and other serious,diseases, tod...ess,of EHA in Vienna, Austria, showed positive res...L) treated with a new,radioimmunotherapy (RAIT) us...
...ivational Reserve" May Also Affect,Alzheimer,s Ris...ire/ -- A new study,suggests that treating risk fa...lood pressure and diabetes, may slow the progressi...eported today at the,2nd Alzheimer,s Association I...in Washington, DC. , Two new studies presented at ...
Other Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 2Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 3Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 4Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 6Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 7
... is the only HER-2 assessment test approved by the...claims: prognosis, adriamycin-based chemotherapy s...al antibody therapy selection. PathVysion is the o...Herceptin® package insert as an appropriate te...
...op® medication nebulizer achieves optimum lung...mented MMAD particle size range is 1.04-1.10 &micr...compressor or air outlet., ,As the world leader i...care providers the assurance of proven technology ...
CK1001 Small Volume Medication Kits
6075-504 Custom Nebulizer Kit
Medicine Products: